How do you discuss the overlap of POTS, Ehlers-Danlos and MCAS with patients?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

Would you consider anti-IL-5 therapy (mepolizumab or benralizumab) to either prevent or treat the more severe manifestations of eosinophilic granulomatosis with polyangiitis, such as "infiltrative" (e.g., cardiomyopathy, pulmonary infiltrates, or gastroenteritis) or "vasculitic" (e.g., neuropathy, palpable purpura, or glomerulonephritis)?

22 Answers

How do you approach the frequency of DEXA scan monitoring for older adults on bisphosphonate therapy during the course of therapy?

11 Answers

What are the clinical prompts that lead you to consider deprescribing bisphosphonate therapy in older adults with osteoporosis?

1 Answers

About Mednet

A community where doctors find answers to medicine's toughest questions.